{"entity":{"type":"insider","cik":"0001726010","url":"/insider/0001726010","json_url":"/insider/0001726010.json","name":"Dethlefs Sven","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":17,"first":"2018-03-14","last":"2023-03-08","span_basis":"filed_date"},"name_variants":[{"name":"Dethlefs Sven","source":"filing","n_filings":17,"first_seen":"2018-03-14","last_seen":"2023-03-08"}],"transactions":[{"id":8723100,"accession":"0001209191-23-017155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-017155","line_url":"/filing/0001209191-23-017155#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58066.0,"shares_display":"58,066","price_per_share":9.4279,"price_display":"9.43","price_state":"stated","total_value":547440.4414,"total_display":"547,440.44","total_whole":"547,440","shares_owned_after":165381.0,"shares_owned_after_display":"165,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8723097,"accession":"0001209191-23-017155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-017155","line_url":"/filing/0001209191-23-017155#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19355.0,"shares_display":"19,355","price_per_share":9.9309,"price_display":"9.93","price_state":"stated","total_value":192212.5695,"total_display":"192,212.57","total_whole":"192,213","shares_owned_after":223447.0,"shares_owned_after_display":"223,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":8152139,"accession":"0001209191-23-014436","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-014436","line_url":"/filing/0001209191-23-014436","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59655.0,"shares_display":"59,655","price_per_share":9.8866,"price_display":"9.89","price_state":"stated","total_value":589785.123,"total_display":"589,785.12","total_whole":"589,785","shares_owned_after":165381.0,"shares_owned_after_display":"165,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-28","filed_date":"2023-03-02","scope":"insider","n_lines":2},{"id":6424661,"accession":"0001209191-22-017035","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-22-017035","line_url":"/filing/0001209191-22-017035#line-5","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6993.0,"shares_display":"6,993","price_per_share":7.3667,"price_display":"7.37","price_state":"stated","total_value":51515.3331,"total_display":"51,515.33","total_whole":"51,515","shares_owned_after":165381.0,"shares_owned_after_display":"165,381","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6424655,"accession":"0001209191-22-017035","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-017035","line_url":"/filing/0001209191-22-017035#line-3","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3904.0,"shares_display":"3,904","price_per_share":7.4825,"price_display":"7.48","price_state":"stated","total_value":29211.68,"total_display":"29,211.68","total_whole":"29,212","shares_owned_after":147422.0,"shares_owned_after_display":"147,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-08","scope":"insider"},{"id":6693672,"accession":"0001209191-22-014467","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-014467","line_url":"/filing/0001209191-22-014467#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4862.0,"shares_display":"4,862","price_per_share":8.1422,"price_display":"8.14","price_state":"stated","total_value":39587.3764,"total_display":"39,587.38","total_whole":"39,587","shares_owned_after":99457.0,"shares_owned_after_display":"99,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-28","filed_date":"2022-03-02","scope":"insider"},{"id":6423703,"accession":"0001209191-22-008412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008412","line_url":"/filing/0001209191-22-008412#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP, North America Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, North America Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, North America Commercial","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4138.0,"shares_display":"4,138","price_per_share":9.0602,"price_display":"9.06","price_state":"stated","total_value":37491.1076,"total_display":"37,491.11","total_whole":"37,491","shares_owned_after":86973.0,"shares_owned_after_display":"86,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-09","filed_date":"2022-02-10","scope":"insider"},{"id":4884133,"accession":"0001209191-21-018510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-018510","line_url":"/filing/0001209191-21-018510#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6012.0,"shares_display":"6,012","price_per_share":10.5661,"price_display":"10.57","price_state":"stated","total_value":63523.3932,"total_display":"63,523.39","total_whole":"63,523","shares_owned_after":77975.7,"shares_owned_after_display":"77,975.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-08","scope":"insider"},{"id":4555096,"accession":"0001209191-21-017756","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-017756","line_url":"/filing/0001209191-21-017756#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":606.0,"shares_display":"606","price_per_share":10.8626,"price_display":"10.86","price_state":"stated","total_value":6582.7356,"total_display":"6,582.74","total_whole":"6,583","shares_owned_after":70057.7,"shares_owned_after_display":"70,057.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider"},{"id":4717477,"accession":"0001209191-21-015826","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-015826","line_url":"/filing/0001209191-21-015826#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7486.0,"shares_display":"7,486","price_per_share":10.8308,"price_display":"10.83","price_state":"stated","total_value":81079.3688,"total_display":"81,079.37","total_whole":"81,079","shares_owned_after":69263.7,"shares_owned_after_display":"69,263.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-01","filed_date":"2021-03-02","scope":"insider"},{"id":4924905,"accession":"0001209191-21-009628","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-009628","line_url":"/filing/0001209191-21-009628","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29657.0,"shares_display":"29,657","price_per_share":12.6945,"price_display":"12.69","price_state":"stated","total_value":376480.7865,"total_display":"376,480.79","total_whole":"376,481","shares_owned_after":59403.7,"shares_owned_after_display":"59,403.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-11","scope":"insider","n_lines":2},{"id":3147449,"accession":"0001209191-20-008162","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-008162","line_url":"/filing/0001209191-20-008162#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5669.0,"shares_display":"5,669","price_per_share":12.27,"price_display":"12.27","price_state":"stated","total_value":69558.63,"total_display":"69,558.63","total_whole":"69,559","shares_owned_after":18060.7,"shares_owned_after_display":"18,060.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-10","filed_date":"2020-02-11","scope":"insider"},{"id":8645367,"accession":"0001209191-19-020156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-020156","line_url":"/filing/0001209191-19-020156#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":632.0,"shares_display":"632","price_per_share":16.6251,"price_display":"16.63","price_state":"stated","total_value":10507.0632,"total_display":"10,507.06","total_whole":"10,507","shares_owned_after":9148.7,"shares_owned_after_display":"9,148.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":8190980,"accession":"0001209191-19-019326","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-019326","line_url":"/filing/0001209191-19-019326#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":647.0,"shares_display":"647","price_per_share":15.6749,"price_display":"15.67","price_state":"stated","total_value":10141.6603,"total_display":"10,141.66","total_whole":"10,142","shares_owned_after":8601.7,"shares_owned_after_display":"8,601.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-14","scope":"insider"},{"id":8692467,"accession":"0001209191-19-016083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-016083","line_url":"/filing/0001209191-19-016083#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":606.0,"shares_display":"606","price_per_share":16.8833,"price_display":"16.88","price_state":"stated","total_value":10231.2798,"total_display":"10,231.28","total_whole":"10,231","shares_owned_after":8057.7,"shares_owned_after_display":"8,057.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-05","scope":"insider"},{"id":5966043,"accession":"0001209191-18-051774","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-051774","line_url":"/filing/0001209191-18-051774#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":23.707,"price_display":"23.71","price_state":"stated","total_value":14816.875,"total_display":"14,816.88","total_whole":"14,817","shares_owned_after":7264.7,"shares_owned_after_display":"7,264.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-20","scope":"insider"},{"id":6201255,"accession":"0001209191-18-045615","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-045615","line_url":"/filing/0001209191-18-045615#line-1","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":21.92,"price_display":"21.92","price_state":"stated","total_value":43840.0,"total_display":"43,840.00","total_whole":"43,840","shares_owned_after":6444.7,"shares_owned_after_display":"6,444.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-03","filed_date":"2018-08-07","scope":"insider"},{"id":6332141,"accession":"0001209191-18-020858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-020858","line_url":"/filing/0001209191-18-020858#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":571.0,"shares_display":"571","price_per_share":17.878,"price_display":"17.88","price_state":"stated","total_value":10208.338,"total_display":"10,208.34","total_whole":"10,208","shares_owned_after":4444.7,"shares_owned_after_display":"4,444.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-19","filed_date":"2018-03-20","scope":"insider"},{"id":6701792,"accession":"0001209191-18-019560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-019560","line_url":"/filing/0001209191-18-019560#line-2","is_derivative":false,"issuer_cik":"0000818686","issuer_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","issuer_ticker":"TEVA","issuer_name_source":null,"issuer_url":"/issuer/0000818686","owner_cik":"0001726010","owner_name":"Dethlefs Sven","owner_display_name":"Dethlefs Sven","owner_url":"/insider/0001726010","role":"Officer (EVP Global Marketing&Portfolio)","role_mark":"O","role_mark_label":"Officer (EVP Global Marketing&Portfolio)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP Global Marketing&Portfolio","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":576.0,"shares_display":"576","price_per_share":19.489,"price_display":"19.49","price_state":"stated","total_value":11225.664,"total_display":"11,225.66","total_whole":"11,226","shares_owned_after":3836.7,"shares_owned_after_display":"3,836.70","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","url":"/issuer/0000818686","role":"Officer (EVP, North America Commercial)","n_filings":17,"first_seen":"2018-03-14","last_seen":"2023-03-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001726010","retrieved_at":"2026-08-24T13:38:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}